Phillipe Abreu

Dr. Phillipe Abreu

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2020 in Transplantation
Verified
Journal Article
Closed access
TITommy Ivanics
Tommy Ivanics
PAPhillipe Abreu
Phillipe Abreu
EMEleonora De Martin
Eleonora De Martin
GSGonzalo Sapisochin
Gonzalo Sapisochin
Despite improvements in postliver transplant outcomes through refinements in perioperative management and surgical techniques, several changing trends in liver transplantation have presented challenges. Mortality on the waitlist remains high. In the United States, Europe, and the United Kingdom, there is an increasing need for liver transplantation, primarily as a result of increased incidence of nonalcoholic steatohepatitis-related cirrhosis and cancer indications. Meanwhile, donor suitability has decreased, as donors are often older and have more comorbidities. Despite a mismatch between organ need and availability, many organs are discarded. Notwithstanding this, many solutions have been developed to overcome these challenges. Innovative techniques in allograft preservation, viability assessment, and reconditioning have allowed the use of suboptimal organs with adequate results. Refinements in surgical procedures, including live donor liver transplantations, have increased the organ pool and are decreasing the time and mortality on the waitlist. Despite many challenges, a similar number of solutions and prospects are on the horizon. This review seeks to explore the changing trends and challenges in liver transplantation and highlight possible solutions and future directions.

1 June 2023 in Cancers
Verified
Journal Article
Open access
PDF file
JMJoao Manzi
Joao Manzi
CHCamilla Oliveira Hoff
Camilla Oliveira Hoff
RFRaphaella De Paula Ferreira
Raphaella De Paula Ferreira
APAgustin Pimentel
Agustin Pimentel
JDJashodeep Datta
Jashodeep Datta
PAPhillipe Abreu
Phillipe Abreu
In 2022, approximately 600,000 cancer deaths were expected; more than 50,000 of those deaths would be from colorectal cancer (CRC). The CRC mortality rate in the US has decreased in recent decades, with a 51% drop between 1976 and 2014. This drop is attributed, in part, to the tremendous therapeutic improvements, especially after the 2000s, in addition to increased social awareness regarding risk factors and diagnostic improvement. Five-fluorouracil, irinotecan, capecitabine, and later oxaliplatin were the mainstays of mCRC treatment from the 1960s to 2002. Since then, more than a dozen drugs have been approved for the disease, betting on a new chapter in medicine, precision oncology, which uses patient and tumor characteristics to guide the therapeutic choice. Thus, this review will summarize the current literature on targeted therapies, highlighting the molecular biomarkers involved and their pathways.

1 November 2019 in JHEP Reports
Verified
Journal Article
Open access
PAPhillipe Abreu
Phillipe Abreu
AGAndre Gorgen
Andre Gorgen
GOGraziano Oldani
Graziano Oldani
THTaizo Hibi
Taizo Hibi
GSGonzalo Sapisochin
Gonzalo Sapisochin
Liver transplantation is widely indicated as a curative treatment for selected patients with hepatocellular carcinoma. However, with recent therapeutic advances, as well as efforts to increase the donor pool, liver transplantation has been carefully expanded to patients with other primary or secondary malignancies in the liver. Cholangiocarcinoma, colorectal and neuroendocrine liver metastases, and hepatic epithelioid haemangioendothelioma are amongst the most relevant new indications. In this review we discuss the fundamental concepts of this ambitious undertaking, as well as the newest indications for liver transplantation, with a special focus on future perspectives within the recently established concept of transplant oncology.

22 August 2012 in World Journal of Emergency Surgery
Verified
Journal Article
Open access
PDF file
AMAntonio C Marttos
Antonio C Marttos
FKFernanda M Kuchkarian
Fernanda M Kuchkarian
PAPhillipe Abreu
Phillipe Abreu
BPBruno Mt Pereira
Bruno Mt Pereira
FCFrancisco S Collet-Silva
Francisco S Collet-Silva
GFGustavo P Fraga
Gustavo P Fraga
Advances in information and communication technologies are changing the delivery of trauma care and education. Telemedicine is a tool that can be used to deliver expert trauma care and education anywhere in the world. Trauma is a rapidly-evolving field requiring access to readily available sources of information. Through videoconferencing, physicians can participate in continuing education activities such as Grand Rounds, seminars, conferences and journal clubs. Exemplary programs have shown promising outcomes of teleconferences such as enhanced learning, professional collaborations, and networking. This review introduces the concept of telemedicine for trauma education, and highlights efforts of programs that are utilizing telemedicine to unite institutions across the world.

1 October 2019 in Current Opinion in Organ Transplantation
Verified
Journal Article
Closed access
ALAshley J.P. Limkemann
Ashley J.P. Limkemann
PAPhillipe Abreu
Phillipe Abreu
GSGonzalo Sapisochin
Gonzalo Sapisochin
Purpose of review: Living donor liver transplantation (LDLT) in the setting of hepatocellular carcinoma (HCC) has been adopted worldwide over the past decade. Many centers have implemented LDLT because of the limited supply of deceased organs, which has also provided an opportunity for centers to expand the indication for transplantation for patients with HCC. Recent findings: Center-specific expanded HCC criteria have proven to be well tolerated in terms of overall and disease-free survival when compared with the standard, Milan criteria. There is a need to overcome size and number as the sole limiters. New technologies to better predict outcomes after liver transplantation for HCC, response to treatments and/or bridging therapies while waiting for a liver transplantation, along with determining tumour behaviour are being incorporated into criteria. Improved outcomes of LDLT for all causes has increased utilization of the procedure for HCC patients worldwide. Summary: LDLT has become a great treatment option for HCC patients. Progressively better understanding of tumour behaviour and different surrogates of tumour biology assessments will allow better patient selection for LDLT.

1 August 2013 in Revista do Colégio Brasileiro de Cirurgiões
Verified
Journal Article
Closed access
PDF file
PAPhillipe Abreu
Phillipe Abreu
ADAnna Luiza Driessen
Anna Luiza Driessen
ACAna Claudia Brenner Affonso da Costa
Ana Claudia Brenner Affonso da Costa
ANAdonis Nasr
Adonis Nasr
ICIwan Augusto Collaço
Iwan Augusto Collaço
FTFlávio Daniel Saavedra Tomasich
Flávio Daniel Saavedra Tomasich
OBJETIVO: avaliar os acidentes com material biológico entre estudantes de medicina estagiando em um pronto-socorro de trauma e identificar as principais situações relacionadas, causas atribuídas e prevenção. MÉTODOS: estudo com abordagem quantitativa. Os dados foram coletados através de um questionário, aplicado via internet, contendo perguntas fechadas de escolha múltipla, referentes a acidentes com material biológico. A amostra obtida foi 100 estudantes. RESULTADOS: trinta e dois se acidentaram com materiais biológicos. As atividades de maior risco foram anestesia local (39,47%), sutura (18,42%) e recapeamento de agulha (15,79%). As principais vias de exposição ao material biológico foram contato com olho ou mucosa, com 34%, através de seringa com agulha com 45%. Após a contaminação, apenas 52% notificaram o acidente ao setor responsável. CONCLUSÃO: as principais causas de acidente encontradas e vias de exposição podem ser atribuídas a diversos fatores, como falta de treinamento e ao não uso de equipamentos de proteção individual. Ações preventivas e educativas são de extrema importância para diminuir a incidência dos acidentes com materiais biológicos e melhorar a conduta pós-exposição. É preciso entender as principais causas atribuídas e situações relacionadas a fim de implantar medidas gerais e eficazes.